Idera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 85   

Articles published

IDRA 2.77 -0.17 (-5.78%)
price chart
Why Idera Pharmaceuticals Inc. Shares Jumped
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Idera Pharmaceuticals Inc. Stock Downgraded (IDRA)
9 Stocks Rallying On Exciting News: Idera Pharmaceuticals Inc (IDRA), Ariad ...  Markets Emerging
Related articles »  
Idera Pharmaceuticals, Inc. Bouncing on Phase 2 Success
Idera Pharmaceuticals' (NASDAQ: IDRA ) stock market rollercoaster ride left it partially recovered from its 25% plunge just over a week ago upon FDA approval of a competing product developed by Celgene (NASDAQ: CELG ) .
Better Psoriasis Treatments Needed Worldwide, Panel Says  Guardian Liberty Voice
Related articles »  
Idera Pharmaceuticals, Inc. (IDRA) in Focus: Stock Stock Surges 17.8%
If you have any questions, please email customer support at or call 800-767-3771 ext. 9339. Idera Pharmaceuticals, Inc. (IDRA - Snapshot Report) was a big mover last session, as the company saw its shares surge nearly 18% on the day.
Related articles »  
Idera Pharmaceutical Up After Market; Big Moves in Agios and Idenix
Idera Pharmaceuticals Inc (IDRA) was up over 4.42% in after-hours trading yesterday after data was released that shows its Toll-like Receptor (TLR) antagonist, IMO-8400, is able to inhibit the spread and survival of B-cell lymphoma cells that carry the ...
Today's Dead Cat Bounce Stock Is Idera Pharmaceuticals (IDRA)
Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, engages in the discovery and development of novel synthetic DNA- and RNA- based drug candidates.
Related articles »  
Biotech Bearish Stocks: Ultragenyx Pharmaceutical (NASDAQ:RARE), OXiGENE ...
Even though there was no significant change, Idera Pharmaceuticals Inc. (NASDAQ:IDRA) cash flow growth rate is severely below the industry average.
Tesla Motors Inc (NASDAQ:TSLA), Once Highfliers Breaking the Curse: Idera ...
Momentum stocks like Frontline Ltd. (NYSE:FRO), Idera Pharmaceuticals Inc (NASDAQ:IDRA), Novavax, Inc. (NASDAQ:NVAX), FX Energy, Inc. (NASDAQ:FXEN) and Dejour Energy Inc (USA) (NYSEMKT:DEJ) all of which made significant gains in 2013 were ...
NASDAQ Losers: Gogo Inc (NASDAQ:GOGO), Galena Biopharma Inc (NASDAQ ...
Idera Pharmaceuticals Inc (NASDAQ:IDRA) recently presented new preclinical data demonstrating the ability of its Toll-like receptor (TLR) antagonist, IMO-8400, to inhibit the survival and proliferation of B-cell lymphoma cells harboring the oncogenic ...
Market Movers- Idera Pharmaceuticals Inc (NASDAQ:IDRA), Eagle Bulk ...  Techsonian (press release)
Related articles »  
Immense Opportunities Ahead For Idera Pharmaceuticals Inc (NASDAQ:IDRA)
Denver, CO, 04/01/2014, ( - Idera Pharmaceuticals Inc (NASDAQ:IDRA) showed signs of strong reversals on Monday, loosing out nearly 11% of the gains on the day.
Idera Pharmaceuticals Inc (NASDAQ:IDRA) Reported Positive Top Line Data For ...  USTrade Voice
FuelCell Energy Inc (NASDAQ:FCEL) recovers, Idera Pharmaceuticals Inc ...  Markets Emerging
Related articles »  
NASDAQ losers: Idera Pharmaceuticals (NASDAQ:IDRA), Money gram ...
Idera Pharmaceuticals Inc (NASDAQ:IDRA) rallied 10.52%, the company recently presented its new pre- clinical data that demonstrates the ability of the TLR or Toll-like receptor antagonist, IMO-8400, for inhibiting survival and the proliferation of the ...
Related articles »